PLAY PODCASTS
An Approach to Psychedelic Therapy Inspired by Indigenous Traditions - Dr. Jeeshan Chowdhury, Founder and CEO of Journey Colab
Episode 433

An Approach to Psychedelic Therapy Inspired by Indigenous Traditions - Dr. Jeeshan Chowdhury, Founder and CEO of Journey Colab

Raise the Line · Dr. Jeeshan Chowdhury, Shiv Gaglani

November 21, 202339m 42s

Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Raise the Line’s in-depth look at the potential use of psychedelic compounds in mental health treatment continues today with a focus on the role they may play in helping people overcome substance use disorders. Our guest is Dr. Jeeshan Chowdhury, whose own mental health journey led him to found Journey Colab, a company combating addiction through psychedelic care while employing a unique stakeholder model that includes indigenous communities in ownership. “We have put 10% of the founding equity of the company into an irrevocable purpose trust so that the land, the traditions and the people that our medicines and our work are inspired from can benefit from it,” explains Chowdhury. He tells host Shiv Gaglani that indigenous traditions also inform how the company approaches psychedelic therapy itself. “When we look at their use, it is always done in the context of an expert healer, often called a shaman, and it's done as part of a very well-honed protocol and in the context of a larger community.” Check out this thoughtful discussion to find out why Chowdhury thinks of the therapeutic use of psychedelics as akin to surgery, and how Journey Colab is working with rehab center partners to integrate psychedelic care through clinical trials with the goal of creating an integrated treatment program.

Mentioned in this episode: https://www.journeycolab.com

If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Topics

drug costspharmacy benefit managersdrug developmentcontinuing educationjourney colabjohns hopkins universityomicrondoctorsmedical degreescoronavirushome caredigital healthhealth insurancewearablesfrontline providersrehabosmosis from elsevierpfizerfdagovernment policypsilocybinmedicareraise the linevirusmachine learningeducation innovationpharmaceuticalshospital staysinterviewnursing schoolflatten the curvemichael carreseelsevieraihealthcare entrepreneursnursing cmenursesprimary carehealthcare capacityhealthcare reformbig pharmaastra zenecacovid-19rare disordershealthcare workforceexpertsspace repetitionmedical educationsam altmanpsychedelic treatmentnursing shortagelsdmedicaidlearning sciencegene editingvalue-based caretechnologyflipped classroommedicare advantagenursing educationnursing educationjeeshan chowdhurysolutionsphysician shortageprovider burnoutcdcepidemicosmosisdelta variantopenairemote monitoringhealthcare systemmark cubanosmosis.orgdecision supportrare diseasesvirus outbreakonline educationallied health professionspublic policycovid19edtechshiv gaglanimdmamodernaphysician assistant educationvivian leechelsea clintonpodcastsnursing degreepsychedelicshospital systemspublic healthdr. ashish jhavaccineseric topolyear of the zebradental educationtestingcenters for disease controlpsychedelic-assisted therapyhealth professionspandemicjohnson & johnsontelehealth